Galderma Labs patent expiration

1. Clobex patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8066975 GALDERMA LABS Foaming composition for washing and treating hair and/or scalp based on an active principle
Jun, 2019

(5 years ago)

US8066976 GALDERMA LABS Foaming compositions for hair care
Jun, 2019

(5 years ago)

US7316810 GALDERMA LABS Foaming composition for washing and treating hair and/or scalp based on an active principle
Jun, 2019

(5 years ago)

US7700081 GALDERMA LABS Foaming compositions for hair care
Jan, 2022

(2 years ago)




Drugs and Companies using CLOBETASOL PROPIONATE ingredient

Market Authorisation Date: 05 February, 2004

Treatment: Topical treatment of scalp psoriasis

Dosage: SHAMPOO

How can I launch a generic of CLOBEX before it's drug patent expiration?
More Information on Dosage

CLOBEX family patents

Family Patents

2. Epiduo Forte patent expiration

EPIDUO FORTE's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8909305 GALDERMA LABS Method and system for activating an application on a mobile device
Dec, 2022

(1 year, 6 months ago)

US8785420 GALDERMA LABS Combination/association of adapalene and benzoyl peroxide for treating acne lesions
Dec, 2022

(1 year, 6 months ago)

US9814690 GALDERMA LABS Gel composition for treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt
Dec, 2022

(1 year, 6 months ago)

US8936800 GALDERMA LABS Gel composition for treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt
Dec, 2022

(1 year, 6 months ago)

US8809305 GALDERMA LABS Administration of adapalene and benzoyl peroxide for the long-term treatment of acne vulgaris
Dec, 2022

(1 year, 6 months ago)

US8445543 GALDERMA LABS Combinations of adapalene and benzoyl peroxide for treating acne lesions
Dec, 2022

(1 year, 6 months ago)

US8703820 GALDERMA LABS Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
Mar, 2023

(1 year, 4 months ago)

US8729127 GALDERMA LABS Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
Mar, 2023

(1 year, 4 months ago)

US9381179 GALDERMA LABS Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
Mar, 2023

(1 year, 4 months ago)

US9387187 GALDERMA LABS Administration of 6[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
Mar, 2023

(1 year, 4 months ago)




Drug Exclusivity Drug Exclusivity Expiration
New Product(NP) Jul 15, 2018

Drugs and Companies using ADAPALENE; BENZOYL PEROXIDE ingredient

Market Authorisation Date: 15 July, 2015

Treatment: Treatment of acne

Dosage: GEL

How can I launch a generic of EPIDUO FORTE before it's drug patent expiration?
More Information on Dosage

EPIDUO FORTE family patents

Family Patents